The Filing
iCapital and HPS Investment Partners filed Form D on May 26, 2026, for the HPS Corporate Lending Offshore Access Fund SPC, targeting $431 million under Regulation D exemption 06b. This represents a dramatic scale-up from the fund's prior raise of $81.9 million in February 2025. The offshore Special Purpose Company structure signals intent to segregate capital by geography or lending vertical while accommodating non-US limited partners without US regulatory friction.
The fund operates through multiple named general partners—a syndicate model rather than a single-manager vehicle. This compartmentalization typically allows co-investment arrangements and parallel capital sourcing from distinct LP bases. For institutional allocators, this structure raises a critical question: what is the operational relationship between the GPs, and who carries primary portfolio management responsibility?
Manager Positioning
HPS Investment Partners is an established credit platform. HPS Investment Partners is a leading global credit investment firm with approximately $80 billion of assets under management, and the HPS Corporate Lending Fund (HLEND) seeks to deliver a stable, monthly income stream by investing in a diversified, high-quality portfolio of predominantly senior secured, floating-rate loans to upper-middle market companies and features targeted monthly dividends and targeted quarterly liquidity with "pass-through" like tax treatment.
iCapital Advisors, by contrast, has not appeared in prior SEC filings before this vehicle. iCapital Advisors, LLC is an investment adviser registered with the Securities and Exchange Commission and acts as an adviser to certain privately offered investment funds. iCapital itself is a fintech platform: the new funding boosted iCapital's valuation to more than $7.5 billion. The platform distributes alternatives to wealth advisors and institutions, but iCapital Advisors' fund management track record remains opaque. Allocators should demand clarity on whether iCapital Advisors is a GP delegated by HPS, or a co-GP with distinct portfolio responsibilities.
Market Timing: Lending Redux
The May 2026 filing date frames directly against a thawing of bank lending. Over the past two years bank lending has shown signs of improvement for both refinancing and new issuance, with U.S. leveraged loan activity averaging about $300 billion per quarter in 2024 through the third quarter of 2025 relative to average activity of $120 billion over the prior three years. This recovery typically suppresses direct lending spreads as banks and club deals compete for larger, less-risky borrowers.
For HPS and iCapital, the timing suggests a pivot toward larger upper-middle-market credits and a race to lock in capital before spreads compress further. The offshore domicile also positions this fund to source capital from European family offices and non-US institutions seeking floating-rate credit exposure without US withholding or reporting friction.
Key Diligence Points
Before committing, allocators must establish: (1) whether the four named GPs carry key-man provisions or fund wind-down triggers; (2) iCapital Advisors' prior track record, AUM, and regulatory history across all strategies—the absence from EDGAR suggests either a new entrant or a delegation that lacks public precedent; (3) whether the offshore structure creates adverse tax or ERISA compliance outcomes for US tax-exempt or defined-benefit LPs; (4) the GP fee structure and any clawbacks tied to loss severity; and (5) the operational separation and decision rights between HPS and iCapital Advisors on sourcing, underwriting, and workout management.
The $431 million target is material but not transformational. The real question is whether this is HPS recycling capital through a new iCapital-branded vehicle to broaden LP access, or a genuine GP partnership where iCapital brings independent sourcing or risk management edge. The Form D alone does not answer that.